| Issue Date | Title | Author(s) |
| 2018-11-15 | LDHA in neuroblastoma is associated with poor outcome and its depletion decreases neuroblastoma growth independent of aerobic glycolysis | Dorneburg, C; Fischer, M; Barth, TFE; Mueller-Klieser, W; Hero, B; Gecht, J; Carter, DR; de Preter, K; Mayer, B; Christner, L; Speleman, F; Marshall, GM; Debatin, KM; Beltinger, C |
| 2022-10-04 | Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory. | Yuan, X; Seneviratne, JA; Du, S; Xu, Y; Chen, Y; Jin, Q; Jin, X; Balachandran, A; Huang, S; Xu, Y; Zhai, Y; Lu, L; Tang, M; Dong, Y; Cheung, BB; Marshall, GM; Shi, W; Carter, DR; Zhang, C |
| 2021-03-03 | A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma | Cheung, BB; Kleynhans, A; Mittra, R; Kim, PY; Holien, JK; Nagy, Z; Ciampa, OC; Seneviratne, JA; Mayoh, C; Raipuria, M; Gadde, S; Massudi, H; Wong, IPL; Tan, O; Gong, A; Suryano, A; Diakiw, SM; Liu, B; Arndt, GM; Liu, T; Kumar, N; Sangfelt, O; Zhu, S; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM |
| 2021-08-01 | Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma. | Xiao, L; Somers, K; Murray, J; Pandher, R; Karsa, M; Ronca, E; Bongers, A; Terry, R; Ehteda, A; Gamble, LD; Issaeva, N; Leonova, KI; O'Connor, A; Mayoh, C; Venkat, P; Quek, H; Brand, J; Kusuma, FK; Pettitt, JA; Mosmann, E; Kearns, A; Eden, G; Alfred, S; Allan, S; Zhai, L; Kamili, A; Gifford, AJ; Carter, DR; Henderson, MJ; Fletcher, JI; Marshall, G; Johnstone, RW; Cesare, AJ; Ziegler, DS; Gudkov, AV; Gurova, KV; Norris, MD; Haber, M |
| 2016-10-11 | MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. | Fabian, J; Opitz, D; Althoff, K; Lodrini, M; Hero, B; Volland, R; Beckers, A; de Preter, K; Decock, A; Patil, N; Abba, M; Kopp-Schneider, A; Astrahantseff, K; Wünschel, J; Pfeil, S; Ercu, M; Künkele, A; Hu, J; Thole, T; Schweizer, L; Mechtersheimer, G; Carter, D; Cheung, BB; Popanda, O; von Deimling, A; Koster, J; Versteeg, R; Schwab, M; Marshall, GM; Speleman, F; Erb, U; Zoeller, M; Allgayer, H; Simon, T; Fischer, M; Kulozik, AE; Eggert, A; Witt, O; Schulte, JH; Deubzer, HE |
| 2016-10-11 | MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. | Fabian, J; Opitz, D; Althoff, K; Lodrini, M; Hero, B; Volland, R; Beckers, A; de Preter, K; Decock, A; Patil, N; Abba, M; Kopp-Schneider, A; Astrahantseff, K; Wünschel, J; Pfeil, S; Ercu, M; Künkele, A; Hu, J; Thole, T; Schweizer, L; Mechtersheimer, G; Carter, D; Cheung, BB; Popanda, O; von Deimling, A; Koster, J; Versteeg, R; Schwab, M; Marshall, GM; Speleman, F; Erb, U; Zoeller, M; Allgayer, H; Simon, T; Fischer, M; Kulozik, AE; Eggert, A; Witt, O; Schulte, JH; Deubzer, HE |
| 2016-06 | Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis. | Carter, DR; Sutton, SK; Pajic, M; Murray, J; Sekyere, EO; Fletcher, J; Beckers, A; De Preter, K; Speleman, F; George, RE; Haber, M; Norris, MD; Cheung, BB; Marshall, GM |
| 2017-05-01 | The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. | Wong, M; Tee, AEL; Milazzo, G; Bell, JL; Poulos, RC; Atmadibrata, B; Sun, Y; Jing, D; Ho, N; Ling, D; Liu, PY; Zhang, XD; Hüttelmaier, S; Wong, JWH; Wang, J; Polly, P; Perini, G; Scarlett, CJ; Liu, T |
| 2019-01-30 | Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma | Gamble, LD; Purgato, S; Murray, J; Xiao, L; Yu, DMT; Hanssen, KM; Giorgi, FM; Carter, DR; Gifford, AJ; Valli, E; Milazzo, G; Kamili, A; Mayoh, C; Liu, B; Eden, G; Sarraf, S; Allan, S; Giacomo, SD; Flemming, CL; Russell, AJ; Cheung, BB; Oberthuer, A; London, WB; Fischer, M; Trahair, TN; Fletcher, JI; Marshall, GM; Ziegler, DS; Hogarty, MD; Burns, MR; Perini, G; Norris, MD; Haber, M |
| 2021-03-25 | An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability | Nagy, Z; Seneviratne, JA; Kanikevich, M; Chang, W; Mayoh, C; Venkat, P; Du, Y; Jiang, C; Salib, A; Koach, J; Carter, DR; Mittra, R; Liu, T; Parker, MW; Cheung, BB; Marshall, GM |
